Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A phase II open label study evaluating safety and efficacy of PEG-Interferon alpha-2a (PEG-IFN, Ro 25-8310) versus Interferon (IFN alpha-2a, Roferon-A) in interferon have patients with chronic hepatitis B.
peg-interferon alpha-2a
NV16037
chronic hepatitis b
Phase 2
 
January 2014

Powered by ideaPoint, Inc.